Sofinnova Investments, Inc. Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$1.5B
Holdings
48
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (48 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics Inc | 1,381,149 | $299.5T | 19616743.41% | |
| 2 | NTRANatera Inc | 3,100,560 | $150.9T | 9881871.38% | |
| 3 | AZNAstraZeneca PLC | 1,697,517 | $121.5T | 7957416.71% | |
| 4 | ISRGIntuitive Surgical Inc | 201,182 | $68.8T | 4505738.46% | |
| 5 | ASNDAscendis Pharma A/S | 754,032 | $67.3T | 4407831.18% | |
| 6 | AVTEAerovate Therapeutics Inc | 3,758,686 | $64.5T | 4222086.46% | |
| 7 | MRKMerck & Co Inc | 527,373 | $60.9T | 3985777.14% | |
| 8 | VERAVera Therapeutics Inc | 3,467,156 | $55.6T | 3644814.01% | |
| 9 | VRTXVertex Pharmaceuticals Inc | 145,300 | $51.1T | 3349069.60% | |
| 10 | EX9Exelixis Inc | 2,560,738 | $48.9T | 3205182.65% | |
| 11 | DC4Dexcom Inc | 370,720 | $47.6T | 3120397.27% | |
| 12 | IDXXIDEXX Laboratories Inc | 70,674 | $35.5T | 2324819.68% | |
| 13 | IMTXImmatics NV | 3,041,487 | $35.1T | 2298892.82% | |
| 14 | SNDXSyndax Pharmaceuticals Inc | 1,582,291 | $33.1T | 2169114.82% | |
| 15 | BSXBoston Scientific Corp | 608,861 | $32.9T | 2157059.29% | |
| 16 | RETAEURReata Pharmaceuticals Inc | 322,471 | $32.9T | 2153512.71% | |
| 17 | CYTKCytokinetics Inc | 843,228 | $27.5T | 1801589.83% | |
| 18 | INBXUSDInhibrx Inc | 998,283 | $25.9T | 1697404.39% | |
| 19 | ZNTLZentalis Pharmaceuticals Inc | 828,005 | $23.4T | 1529899.83% | |
| 20 | INZYInozyme Pharma Inc | 3,655,308 | $20.4T | 1333540.26% | |
| 21 | VIRVir Biotechnology Inc | 788,117 | $19.3T | 1266237.57% | Put |
| 22 | GONGeron Corp | 5,429,155 | $17.4T | 1141469.30% | |
| 23 | BAXBaxter Intl Inc | 362,200 | $16.5T | 1080834.29% | |
| 24 | IDYAIDEAYA Biosciences Inc | 664,746 | $15.6T | 1023176.47% | |
| 25 | IMGNEURImmunoGen Inc | 827,318 | $15.6T | 1022518.88% | |
| 26 | ARGXargenx SE | 39,921 | $15.6T | 1019042.25% | |
| 27 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $14.9T | 975861.95% | |
| 28 | RVMDRevolution Medicines Inc | 520,377 | $13.9T | 911735.44% | |
| 29 | AXSMAxsome Therapeutics Inc | 179,242 | $12.9T | 843633.74% | |
| 30 | MRNS*Marinus Pharmaceuticals Inc | 1,162,619 | $12.6T | 826978.43% | Call |
| 31 | PTCTPTC Therapeutics Inc | 260,443 | $10.6T | 693767.29% | |
| 32 | GRTXGalera Therapeutics Inc | 3,083,712 | $9.6T | 630166.53% | |
| 33 | REPLReplimune Group Inc | 348,889 | $8.1T | 530611.27% | |
| 34 | AGENEURAgenus Inc | 4,909,132 | $7.9T | 514460.02% | |
| 35 | TCE2Celldex Therapeutics Inc | 197,758 | $6.7T | 439485.83% | |
| 36 | DYNDyne Therapeutics Inc | 441,048 | $5.0T | 324986.51% | |
| 37 | NXTCNextcure Inc | 2,671,856 | $4.8T | 315001.43% | |
| 38 | —Nucana PLC | 5,599,999 | $4.4T | 289762.36% | |
| 39 | FGENEURFibroGen Inc | 1,537,567 | $4.2T | 271909.75% | Put |
| 40 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $3.5T | 230924.34% | |
| 41 | —Nucana PLC | 2,400,000 | $1.9T | 124183.90% | |
| 42 | PDSBPDS Biotechnology Corp | 142,635 | $717.5B | 46991.68% | |
| 43 | —Fusion Pharmaceuticals Inc | 117,099 | $546.9B | 35817.62% | |
| 44 | YB4PSavara Inc | 96,248 | $307.5B | 20141.37% | |
| 45 | ALLKGUSDAllakos Inc | 62,465 | $272.3B | 17838.14% | |
| 46 | —Synlogic Inc | 574,972 | $247.2B | 16193.55% | |
| 47 | MIRMMirum Pharmaceuticals Inc | 9,089 | $235.1B | 15400.64% | |
| 48 | SPRBSpruce Biosciences Inc | 58,029 | $124.8B | 8171.64% |